Key result
Respiratory sinus arrhythmia pacing increases cardiac output ~20% vs monotonic pacing in ovine heart failure.
Why the study?
Respiratory sinus arrhythmia is lost in cardiovascular disease and current pacemakers cannot restore it, prompting investigation into whether restoring it in heart failure improves cardiac function.
Does respiratory sinus arrhythmia (RSA) pacing improve cardiac function in an ovine model of heart failure with reduced ejection fraction?
Does respiratory sinus arrhythmia (RSA) pacing improve cardiac function in an ovine model of heart failure with reduced ejection fraction?
Effect estimate: 1.4 L/min (20%) increase
Reinstating respiratory sinus arrhythmia in an ovine model of heart failure significantly improves cardiac output and reverses structural remodeling compared to conventional monotonic pacing.
Does not support clinical adoption; leaves open translation of RSA pacing benefits to human HFrEF.
Heart rate variability (HRV) is a crucial indicator of cardiovascular health. Low HRV is correlated with disease severity and mortality in heart failure. Heart rate increases and decreases with each breath in normal physiology termed respiratory sinus arrhythmia (RSA). RSA is highly evolutionarily conserved, most prominent in the young and athletic and is lost in cardiovascular disease. Despite this, current pacemakers either pace the heart in a metronomic fashion or sense activity in the sinus node. If RSA has been lost in cardiovascular disease current pacemakers cannot restore it. We hypothesized that restoration of RSA in heart failure would improve cardiac function. Restoration of RSA in heart failure was assessed in an ovine model of heart failure with reduced ejection fraction. Conscious 24 h recordings were made from three groups, RSA paced (n = 6), monotonically paced (n = 6) and heart failure time control (n = 5). Real-time blood pressure, cardiac output, heart rate and diaphragmatic EMG were recorded in all animals. Respiratory modulated pacing was generated by a proprietary device (Ceryx Medical) to pace the heart with real-time respiratory modulation. RSA pacing substantially increased cardiac output by 1.4 L/min (20%) compared to contemporary (monotonic) pacing. This increase in cardiac output led to a significant decrease in apnoeas associated with heart failure, reversed cardiomyocyte hypertrophy, and restored the T-tubule structure that is essential for force generation. Re-instating RSA in heart failure improves cardiac function through mechanisms of reverse re-modelling; the improvement observed is far greater than that seen with current contemporary therapies. These findings support the concept of re-instating RSA as a regime for patients who require a pacemaker.
No takes yet. Share an insight, caveat, or question.
Shanks et al. (2022) studied Heart failure with reduced ejection fraction (n=17). Respiratory sinus arrhythmia (RSA) pacing vs. Monotonic pacing and heart failure time control was evaluated on Cardiac output (1.4 L/min (20%) increase). Respiratory sinus arrhythmia pacing substantially increased cardiac output by 1.4 L/min (20%) compared to monotonic pacing in an ovine model of heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: